by Netherlands Cancer Institute Preparing tumor-infiltrating lymphocyte therapy for melanoma patients in the lab. Credit: NKI A patient’s own immune cells, multiplied into an army of billions of immune cells in a lab, can be used as a living medicine against metastatic melanoma, an aggressive form of skin cancer, as the TIL trial has shown....
